Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Preclinical
23 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
PAO-02-24-CL-10
Failing Fast
Maximizing Resources and Potential for Success by Failing Fast
PAO-10-23-CL-02
Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
PAO-06-23-CL-04
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
PAO-05-23-CL-03
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
PR-M05-22-04
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
PAO-02-21-CL-04
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
PAO-11-20-CL-01
Preclinical Data
Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017
PR-M03-19-NI-053
Viral Vectors
Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing
PAP-Q1-2019-CL-020
Advisory Board
Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic
PR-M12-18-NI-079
Preclinical Data
Encouraging Preclinical Data for Anticancer Drugs Reported by Verseon
PAO-M04-18-NI-019
Preclinical Data
Syros Announces New Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer
PR-M04-18-NI-67
Preclinical Data
Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia
PR-M04-18-NI-56
Acquisition
Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio
PR-M04-18-NI-34
Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope
PR-M03-18-NI-021
Drug Discovery
Defense Department Commits $16 Million to Fight Bacterial Bioweapons
PAO-M01-18-NI-010
Increasing the Chances of Finding the Best Possible CRO/CMO Fit
MCP-M05-16-NI-001
Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success
PAP-Q02-16-CL-005
Bioreactor Preferences from an Outsourcing Perspective – Part I
PMP-M02-15-NI-001
Strategic Outsourcing Often Means Combining Functional and Full-Service CROs
LSL-M03-13-NI-003
The Right Preformulation / Formulation Outsourcing Partner Can Alleviate Challenges To Reducing Costs
CIO-M09-12-NI-001
Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput
LSL-M05-12-NI-002